The Trump administration is refocusing on RFK Jr.’s vaccine priorities. The CDC vaccine committee will vote again on hepatitis B guidelines.

Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the childhood vaccine schedule, potentially delaying a dose of the hepatitis B vaccine given to newborns by weeks or even years.

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that policymakers set clear elimination targets for hepatitis B, coordinate efforts, enhance surveillance, and create supportive regulatory environments to support this.

The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute hepatitis C virus (HCV) infection, according to results from a multicenter phase IIIb trial.

Findings showed that in patients treated with glecaprevir/pibrentasvir, the overall SVR12 rate was 96%, with 0 patients experiencing virologic failure. The Food and ...

Between April 5 and May 26 of 2022, hundreds of cases of viral hepatitis in children were diagnosed in 33 countries, according to the World Health Organization. Compared with previous outbreaks of viral hepatitis in children, these cases were especially ...

A new study published by the Centers for Disease Control and Prevention (CDC) today, "Acute Hepatitis and Adenovirus Infection Among Children - Alabama, October 2021–February 2022" provides additional clinical and epidemiologic information from an ...